Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) announced the successful completion of its acquisition of PharmaLex Holding GmbH, effective January 1, 2023. This strategic move marks a significant development for the company as it expands its global reach and capabilities in the pharmaceutical services sector. The acquisition is expected to enhance Cencora's offerings and strengthen its position in the market, potentially leading to new growth opportunities and increased value for shareholders.
Key Highlights
- 1Completion of the PharmaLex Holding GmbH acquisition effective January 1, 2023.
- 2The acquisition was previously announced and has now been finalized.
- 3PharmaLex Holding GmbH is now part of Cencora, Inc.
- 4This event signifies a strategic expansion of Cencora's global operations and service offerings.
- 5The company released a press release on January 3, 2023, announcing the closing of the transaction.
- 6The press release is filed as an exhibit (Exhibit 99.1) to this 8-K filing.
Frequently Asked Questions
The main event is the completion of Cencora, Inc.'s acquisition of PharmaLex Holding GmbH, which became effective on January 1, 2023.
The acquisition is expected to expand Cencora's global presence and enhance its capabilities within the pharmaceutical services industry, positioning the company for future growth and market strength.
More details can be found in the press release issued by Cencora on January 3, 2023, which is included as Exhibit 99.1 in this 8-K filing.
The filing mentions AmerisourceBergen Corporation completing the acquisition, and the summary notes 'formerly AmerisourceBergen Corporation', indicating a recent or upcoming name change to Cencora, Inc.